Skip to main content

Peer Review reports

From: Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice

Original Submission
17 Jan 2021 Submitted Original manuscript
30 Jan 2021 Reviewed Reviewer Report - Ugur Ozbek
9 Feb 2021 Reviewed Reviewer Report - Anna Jakubowska
12 Feb 2021 Author responded Author comments - Bettina Meiser
Resubmission - Version 2
12 Feb 2021 Submitted Manuscript version 2
23 Mar 2021 Reviewed Reviewer Report - Anna Jakubowska
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 Mar 2021 Editorially accepted
9 Apr 2021 Article published 10.1186/s13053-021-00180-3

You can find further information about peer review here.

Back to article page

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287